These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2935320

  • 1. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
    Tin F, Hlaing N, Tun T, Win S, Lasserre R.
    Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320
    [Abstract] [Full Text] [Related]

  • 2. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
    de Souza JM, Sheth UK, Wernsdorfer WH, Trigg PI, Doberstyn EB.
    Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
    [Abstract] [Full Text] [Related]

  • 3. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
    Ekue JM, Phiri DE, Sheth UK, Mukunyandela M.
    Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
    [Abstract] [Full Text] [Related]

  • 4. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
    de Souza JM, Sheth UK, de Oliveira RM, Gomes AT, Cavalcante EQ.
    Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
    [Abstract] [Full Text] [Related]

  • 5. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
    de Souza JM, Sheth UK, de Oliveira RM, Roulet H, de Souza SD.
    Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397
    [Abstract] [Full Text] [Related]

  • 6. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
    Harinasuta T, Bunnag D, Vanijanond S, Charoenlarp P, Suntharasmai P, Chitamas S, Sheth UK, Wernsdorfer WH.
    Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
    Kollaritsch H, Stemberger H, Mailer H, Kremsner P, Kollaritsch R, Leimer R, Wiedermann G.
    Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
    [Abstract] [Full Text] [Related]

  • 10. Comparative drug trial of a sulfadoxine/pyrimethamine and a sulfalene/pyrimethamine combination against Plasmodium falciparum infections in semi-immune populations of Burma.
    Tin F, Nyunt-Hlaing.
    Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):238-48. PubMed ID: 6239381
    [Abstract] [Full Text] [Related]

  • 11. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C, Eberlé F, Gazin P, Kouka-Bemba D, Gelas H, Jambou R.
    Bull Soc Pathol Exot; 1990 Jun; 83(1):61-5. PubMed ID: 2190706
    [Abstract] [Full Text] [Related]

  • 12. The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
    Myint PT, Shwe T.
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):223-5. PubMed ID: 3313739
    [Abstract] [Full Text] [Related]

  • 13. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
    Niklewski G, Landscheidt H, Glasner H.
    Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058
    [No Abstract] [Full Text] [Related]

  • 14. Clinical trial of fansimef in Indian patients of P. falciparum malaria.
    Asthana OP, Tangri AN, Nityanand S.
    Indian J Malariol; 1988 Dec; 25(2):89-96. PubMed ID: 3077373
    [No Abstract] [Full Text] [Related]

  • 15. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
    Ellis-Pegler RB, Beeching NJ, Eales M, Fraser AG, Wells AU.
    Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
    Guo XB, Arnold K, Fu LC, Chen PQ, Li GQ.
    Trans R Soc Trop Med Hyg; 1988 Aug; 82(4):538-40. PubMed ID: 3076709
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
    Smithuis F, Shahmanesh M, Kyaw MK, Savran O, Lwin S, White NJ.
    Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.